SG11202102028SA - Method for producing fibroblast, and g-csf-positive fibroblast mass - Google Patents
Method for producing fibroblast, and g-csf-positive fibroblast massInfo
- Publication number
- SG11202102028SA SG11202102028SA SG11202102028SA SG11202102028SA SG11202102028SA SG 11202102028S A SG11202102028S A SG 11202102028SA SG 11202102028S A SG11202102028S A SG 11202102028SA SG 11202102028S A SG11202102028S A SG 11202102028SA SG 11202102028S A SG11202102028S A SG 11202102028SA
- Authority
- SG
- Singapore
- Prior art keywords
- fibroblast
- csf
- mass
- positive
- producing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/33—Fibroblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70542—CD106
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0656—Adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2304—Interleukin-4 (IL-4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/25—Tumour necrosing factors [TNF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Botany (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018160898 | 2018-08-29 | ||
PCT/JP2019/033835 WO2020045547A1 (ja) | 2018-08-29 | 2019-08-29 | 線維芽細胞の製造方法及びg-csf陽性線維芽細胞集団 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202102028SA true SG11202102028SA (en) | 2021-03-30 |
Family
ID=69642802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202102028SA SG11202102028SA (en) | 2018-08-29 | 2019-08-29 | Method for producing fibroblast, and g-csf-positive fibroblast mass |
Country Status (10)
Country | Link |
---|---|
US (1) | US20210254009A1 (ko) |
EP (1) | EP3845635A4 (ko) |
JP (2) | JP6883904B2 (ko) |
KR (1) | KR20210049892A (ko) |
CN (1) | CN112639082A (ko) |
AU (1) | AU2019332400A1 (ko) |
CA (1) | CA3110831A1 (ko) |
IL (1) | IL281081B (ko) |
SG (1) | SG11202102028SA (ko) |
WO (1) | WO2020045547A1 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020045547A1 (ja) | 2018-08-29 | 2020-03-05 | 株式会社メトセラ | 線維芽細胞の製造方法及びg-csf陽性線維芽細胞集団 |
CA3174551A1 (en) * | 2020-03-04 | 2021-09-10 | Metcela Inc. | Fibroblast having enhanced erythropoietin production ability |
JP7233147B2 (ja) * | 2021-03-04 | 2023-03-06 | 株式会社メトセラ | リンパ管新生促進因子発現線維芽細胞及びそれを含む医薬組成物 |
WO2023037868A1 (ja) | 2021-09-08 | 2023-03-16 | 株式会社メトセラ | 線維芽細胞を含む腎疾患治療用医薬組成物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1886150B (zh) * | 2003-10-27 | 2010-05-26 | 学校法人庆应义塾 | 含有g-csf的成纤维细胞动员剂及创伤治疗剂 |
US9987310B2 (en) * | 2013-11-27 | 2018-06-05 | University Of Louisville Research Foundation, Inc. | Cardiac progenitor cells and methods of use therefor |
WO2016006262A1 (ja) | 2014-07-11 | 2016-01-14 | 貴紘 岩宮 | 心臓細胞培養材料 |
CN107881145A (zh) * | 2016-09-26 | 2018-04-06 | 新乡医学院 | 一种分选大鼠心成纤维细胞cd90+亚群的方法及其应用 |
ES2885080T3 (es) | 2017-02-24 | 2021-12-13 | Metcela Inc | Composición inyectable que comprende fibroblastos para su utilización en el tratamiento de cardiopatías |
WO2020045547A1 (ja) | 2018-08-29 | 2020-03-05 | 株式会社メトセラ | 線維芽細胞の製造方法及びg-csf陽性線維芽細胞集団 |
-
2019
- 2019-08-29 WO PCT/JP2019/033835 patent/WO2020045547A1/ja unknown
- 2019-08-29 IL IL281081A patent/IL281081B/en unknown
- 2019-08-29 EP EP19856084.9A patent/EP3845635A4/en active Pending
- 2019-08-29 KR KR1020217009135A patent/KR20210049892A/ko unknown
- 2019-08-29 CA CA3110831A patent/CA3110831A1/en active Pending
- 2019-08-29 CN CN201980056534.7A patent/CN112639082A/zh active Pending
- 2019-08-29 AU AU2019332400A patent/AU2019332400A1/en active Pending
- 2019-08-29 JP JP2020539572A patent/JP6883904B2/ja active Active
- 2019-08-29 SG SG11202102028SA patent/SG11202102028SA/en unknown
-
2021
- 2021-02-26 US US17/187,459 patent/US20210254009A1/en active Pending
- 2021-04-28 JP JP2021076105A patent/JP7428389B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JPWO2020045547A1 (ja) | 2021-02-15 |
IL281081B (en) | 2022-07-01 |
KR20210049892A (ko) | 2021-05-06 |
JP7428389B2 (ja) | 2024-02-06 |
EP3845635A4 (en) | 2022-06-15 |
AU2019332400A1 (en) | 2021-04-01 |
US20210254009A1 (en) | 2021-08-19 |
IL281081A (en) | 2021-04-29 |
CN112639082A (zh) | 2021-04-09 |
EP3845635A1 (en) | 2021-07-07 |
JP6883904B2 (ja) | 2021-06-09 |
WO2020045547A1 (ja) | 2020-03-05 |
CA3110831A1 (en) | 2020-03-05 |
JP2021118728A (ja) | 2021-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201907244D0 (en) | Method | |
IL281081A (en) | Method to generate G-CSF positive fibroblast and fibroblastic mass | |
EP3581354A4 (en) | PREFORM ELEMENT, PREFORM THEREFOR AND METHOD FOR PRODUCING IT | |
EP3851549A4 (en) | RAIL AND RAIL MANUFACTURING METHOD | |
GB2582169B (en) | Authentication method | |
EP3646745A4 (en) | HAIR PIECE, METHOD FOR MANUFACTURING A HAIR PIECE AND METHOD FOR TREATING A HAIR PIECE | |
GB2572610B (en) | Composition, methods for its production, and its use | |
EP3636087A4 (en) | METHOD OF MANUFACTURING A MATERIAL CONTAINING CLOTHING AND CORNICATED CLOTHING | |
EP3633713A4 (en) | METHOD FOR MANUFACTURING A STRUCTURE AND STRUCTURE | |
EP3572392A4 (en) | PROCESS FOR THE PRODUCTION OF FLUORENYLIDENEDIALLYLPHENOLS AND FLUORENYLIDENEDIALLYLPHENOLS | |
PT3735405T (pt) | Processo para fabrico de di-isocianatos de metilenodifenileno e poli-isocianatos de polimetileno-polifenileno | |
PL3733651T3 (pl) | Sposób wytwarzania kalkobutrolu | |
GB2600039B (en) | Structure, and method for manufacturing same | |
EP3604566A4 (en) | RAIL AND METHOD FOR THE PRODUCTION THEREOF | |
GB201907782D0 (en) | Method | |
GB201900940D0 (en) | Method | |
GB201900647D0 (en) | Method | |
EP3550466C0 (en) | PUF FILM AND ITS PRODUCTION METHOD | |
EP3673745A4 (en) | BREEDING TUNA AND ITS USE AND METHOD FOR PRODUCING BREEDING TUNA | |
ZA202202618B (en) | Card and method for producing the card | |
HUE050176T2 (hu) | Tömör alkatrész és a készítésére szolgáló eljárás | |
EP3998146A4 (en) | OBJECT FILLED WITH RESIN AND METHOD OF PRODUCTION | |
EP3838926C0 (en) | MODIFIED STARCH, USE THEREOF, AND METHOD FOR PRODUCING THE MODIFIED STARCH | |
GB202014758D0 (en) | Method for producing urea | |
GB201901532D0 (en) | Method |